The Value of a Histamine H2-Receptor Antagonist in the Management of Patients with the Zollinger-Ellison Syndrome
Authors:
- Charles T. RichardsonCRCharles T. Richardson
- John H. WalshJWJohn H. Walsh
- 15 January 1976
- journal article
- case report
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 294 (3) , 133-135
Abstract
Inhibition of acid secretion by an H2-receptor antagonist (metiamide) was assessed in three patients with the Zollinger-Ellison syndrome. Metiamide (200 or 300 mg) inhibited acid secretion transiently (2 1/2 hours) by 85 to 100 per cent in all patients. Although anticholinergic drugs alone inhibited acid secretion by only 0 to 35 per cent in these patients, the combination of metiamide and anticholinergic markedly prolonged the inhibitory effect of metiamide. Total gastrectomy was refused by one patient, and was impossible in another; both were treated with metiamide and anticholinergic for five and 10 months. A third patient was treated with metiamide and anticholinergic for three weeks in preparation for total gastrectomy. Ulcer pain and diarrhea dirappeared, and each gained weight. H2-receptor antagonists may be useful in the treatment of some patients with the Zollinger-Ellison syndrome. (N Engl J Med 294:133–135,1976)Keywords
This publication has 7 references indexed in Scilit:
- Aspects of the effect of metiamide on pentagastrin-stimulated and basal gastric secretion of acid and pepsin in man.Gut, 1975
- NEUTROPENIA ASSOCIATED WITH METIAMIDEThe Lancet, 1975
- Definition and Antagonism of Histamine H2-receptorsNature, 1972
- VARIABILITY OF GASTRIC SECRETION IN PATIENTS WITH AND WITHOUT THE ZOLLINGER-ELLISON SYNDROMEThe Lancet, 1967
- The Determination of Gastric Acidity by the Glass ElectrodeGastroenterology, 1965
- ZOLLINGER-ELLISON SYNDROME TREATED WITH POLDINE METHYL METHOSULPHATEThe Lancet, 1962
- Optimal Effective Dose of Anticholinergic Drug in Peptic Ulcer TherapyArchives of internal medicine (1960), 1956